Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: Rocketman who wrote (800)	1/7/1999 2:44:00 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 3202

Humor (well not really) I was going through all the crap that piles up on my desk, and found a piece of scratch paper with buy R-INCY $22. So this note must have been written in September or October. Well to make a short story long, I see now that I never did buy that for my wife, instead I put her in GZTC at 2 1/2...and got her out of that at $4. So far so good. Then I got her some XOMA at $2, TGEN at $1 and BTRN at 1 5/8...super, out of those at $3, $1 3/8, and $2. There are a few trades which were a wash, and a few scalping operations, nothing too interesting. Okay, one more and then I'll break your heart. In with SIBI at $4...still holding that. Here we finally come to the stinker, the trade gone bad, the, er, long term investment as I call the thing that happens which means you suddenly cant trade anymore. *Bought CNSI at 1 3/8* Oops. Oh yeah...I didn't get her a little, I was going for the big one with cnsi. In just a few days, several months work down the toilet. Sure wish I'd bought that INCY and just walked away. Thank goodness she doesn't read my messages here on SI. Told you I'd break your heart. --MM

To: Rocketman who wrote (800)	1/12/1999 9:06:00 AM
From: Biotech Jim	Read Replies (1) \| Respond to of 3202

Nature Genetics has a January supplement issue devoted to DNA microarrays and their use and is entitled "The Chipping Forecast". There are several excellent articles that not only describe the technological background and breakthroughs, but also discuss the use of the microarrays in several types of model systems. I guess the question is whether this technology will have the impact to rival PCR or the development of recombinant DNA technology, or whether it will be viewed in the new millennium as simply another technical advance akin to the development of YACs or the automation of DNA sequencing. I think it will have the impact of the former. BJ